The COVID-19 pandemic has put an unprecedented burden on healthcare systems worldwide. This has hampered the management of several highly prevalent clinical conditions in the country, including diabetes, cancer, and coronary heart diseases. Very little is known about the pandemic’s effects on the management of acute coronary syndrome (ACS). ACS is a group of clinical symptoms associated with acute myocardial ischemia, unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI).
ACS requires prompt diagnosis and care that involves a thorough assessment, physical examination of patients, electrocardiography, radiology findings, and cardiac biomarker tests. This helps in early risk identification and is essential for further treatment. Since facilities in the intensive care unit (ICU) have become a priority for COVID…
